866-997-4948(US-Canada Toll Free)

United States Opioids Drugs Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 95 Pages

Notes:
Sales, means the sales volume of Opioids Drugs
Revenue, means the sales value of Opioids Drugs

This report studies sales (consumption) of Opioids Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Sanofi-aventis US LLC
Johnson & Johnson
Teva pharmaceuticals
Purdue Pharma
Pfizer
Orexo Pharmaceuticals
Endo Pharmaceuticals
AbbVie
Allergan
Hospira

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Hydrocodone (e.g., Vicodin)
Codeine
Oxycodone (e.g., OxyContin, Percocet)
Morphine (e.g., Kadian, Avinza)
Others
Split by applications, this report focuses on sales, market share and growth rate of Opioids Drugs in each application, can be divided into
Neuropathic pain treatment
Orthopedic pain treatment
Other pain treatment

Table of Contents

United States Opioids Drugs Market Report 2017
1 Opioids Drugs Overview
1.1 Product Overview and Scope of Opioids Drugs
1.2 Classification of Opioids Drugs
1.2.1 Hydrocodone (e.g., Vicodin)
1.2.2 Codeine
1.2.3 Oxycodone (e.g., OxyContin, Percocet)
1.2.4 Morphine (e.g., Kadian, Avinza)
1.2.5 Others
1.3 Application of Opioids Drugs
1.3.1 Neuropathic pain treatment
1.3.2 Orthopedic pain treatment
1.3.3 Other pain treatment
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Opioids Drugs (2012-2022)
1.4.1 United States Opioids Drugs Sales and Growth Rate (2012-2022)
1.4.2 United States Opioids Drugs Revenue and Growth Rate (2012-2022)

2 United States Opioids Drugs Competition by Manufacturers
2.1 United States Opioids Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Opioids Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Opioids Drugs Average Price by Manufactures (2015 and 2016)
2.4 Opioids Drugs Market Competitive Situation and Trends
2.4.1 Opioids Drugs Market Concentration Rate
2.4.2 Opioids Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Opioids Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Opioids Drugs Sales and Market Share by States (2012-2017)
3.2 United States Opioids Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Opioids Drugs Price by States (2012-2017)

4 United States Opioids Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Opioids Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Opioids Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Opioids Drugs Price by Type (2012-2017)
4.4 United States Opioids Drugs Sales Growth Rate by Type (2012-2017)

5 United States Opioids Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Opioids Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Opioids Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Opioids Drugs Manufacturers Profiles/Analysis
6.1 Sanofi-aventis US LLC
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Opioids Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Sanofi-aventis US LLC Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
6.2.2 Opioids Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Johnson & Johnson Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Teva pharmaceuticals
6.3.2 Opioids Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Teva pharmaceuticals Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Purdue Pharma
6.4.2 Opioids Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Purdue Pharma Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Pfizer
6.5.2 Opioids Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pfizer Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Orexo Pharmaceuticals
6.6.2 Opioids Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Orexo Pharmaceuticals Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Endo Pharmaceuticals
6.7.2 Opioids Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Endo Pharmaceuticals Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 AbbVie
6.8.2 Opioids Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 AbbVie Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Allergan
6.9.2 Opioids Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Allergan Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Hospira
6.10.2 Opioids Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Hospira Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Opioids Drugs Manufacturing Cost Analysis
7.1 Opioids Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Opioids Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Opioids Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Opioids Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Opioids Drugs Market Forecast (2017-2022)
11.1 United States Opioids Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Opioids Drugs Sales Forecast by Type (2017-2022)
11.3 United States Opioids Drugs Sales Forecast by Application (2017-2022)
11.4 Opioids Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Opioids Drugs
Table Classification of Opioids Drugs
Figure United States Sales Market Share of Opioids Drugs by Type in 2015
Figure Hydrocodone (e.g., Vicodin) Picture
Figure Codeine Picture
Figure Oxycodone (e.g., OxyContin, Percocet) Picture
Figure Morphine (e.g., Kadian, Avinza) Picture
Figure Others Picture
Table Application of Opioids Drugs
Figure United States Sales Market Share of Opioids Drugs by Application in 2015
Figure Neuropathic pain treatment Examples
Figure Orthopedic pain treatment Examples
Figure Other pain treatment Examples
Figure United States Opioids Drugs Sales and Growth Rate (2012-2022)
Figure United States Opioids Drugs Revenue and Growth Rate (2012-2022)
Table United States Opioids Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Opioids Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Opioids Drugs Sales Share by Manufacturers
Figure 2016 Opioids Drugs Sales Share by Manufacturers
Table United States Opioids Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Opioids Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Opioids Drugs Revenue Share by Manufacturers
Table 2016 United States Opioids Drugs Revenue Share by Manufacturers
Table United States Market Opioids Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Opioids Drugs Average Price of Key Manufacturers in 2015
Figure Opioids Drugs Market Share of Top 3 Manufacturers
Figure Opioids Drugs Market Share of Top 5 Manufacturers
Table United States Opioids Drugs Sales by States (2012-2017)
Table United States Opioids Drugs Sales Share by States (2012-2017)
Figure United States Opioids Drugs Sales Market Share by States in 2015
Table United States Opioids Drugs Revenue and Market Share by States (2012-2017)
Table United States Opioids Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Opioids Drugs by States (2012-2017)
Table United States Opioids Drugs Price by States (2012-2017)
Table United States Opioids Drugs Sales by Type (2012-2017)
Table United States Opioids Drugs Sales Share by Type (2012-2017)
Figure United States Opioids Drugs Sales Market Share by Type in 2015
Table United States Opioids Drugs Revenue and Market Share by Type (2012-2017)
Table United States Opioids Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Opioids Drugs by Type (2012-2017)
Table United States Opioids Drugs Price by Type (2012-2017)
Figure United States Opioids Drugs Sales Growth Rate by Type (2012-2017)
Table United States Opioids Drugs Sales by Application (2012-2017)
Table United States Opioids Drugs Sales Market Share by Application (2012-2017)
Figure United States Opioids Drugs Sales Market Share by Application in 2015
Table United States Opioids Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Opioids Drugs Sales Growth Rate by Application (2012-2017)
Table Sanofi-aventis US LLC Basic Information List
Table Sanofi-aventis US LLC Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi-aventis US LLC Opioids Drugs Sales Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Opioids Drugs Sales Market Share (2012-2017)
Table Teva pharmaceuticals Basic Information List
Table Teva pharmaceuticals Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva pharmaceuticals Opioids Drugs Sales Market Share (2012-2017)
Table Purdue Pharma Basic Information List
Table Purdue Pharma Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Purdue Pharma Opioids Drugs Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Opioids Drugs Sales Market Share (2012-2017)
Table Orexo Pharmaceuticals Basic Information List
Table Orexo Pharmaceuticals Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Orexo Pharmaceuticals Opioids Drugs Sales Market Share (2012-2017)
Table Endo Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Endo Pharmaceuticals Opioids Drugs Sales Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Opioids Drugs Sales Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Opioids Drugs Sales Market Share (2012-2017)
Table Hospira Basic Information List
Table Hospira Opioids Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hospira Opioids Drugs Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioids Drugs
Figure Manufacturing Process Analysis of Opioids Drugs
Figure Opioids Drugs Industrial Chain Analysis
Table Raw Materials Sources of Opioids Drugs Major Manufacturers in 2015
Table Major Buyers of Opioids Drugs
Table Distributors/Traders List
Figure United States Opioids Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Opioids Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Opioids Drugs Production Forecast by Type (2017-2022)
Table United States Opioids Drugs Consumption Forecast by Application (2017-2022)
Table United States Opioids Drugs Sales Forecast by States (2017-2022)
Table United States Opioids Drugs Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *